Company PhoenixBio Co., Ltd.

Equities

6190

JP3803010002

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-17 am EDT			5-day change	1st Jan Change
496 ^JPY	-5.34%		+0.40%	+6.44%

2023	PhoenixBio Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	CI
2022	PhoenixBio Co., Ltd. announced that it expects to receive ¥1.92 million in funding from Milestone Capital Management Co., Ltd.	CI

PhoenixBio Co., Ltd. is a Japan-based company mainly engaged in provision of contract research services of drug development, which uses PXB mouse. The PXB Mouse segment is engaged in the development of technology to create PXB Mouse in which more than 70% of mouse livers are replaced with human hepatocytes. The product called PXB Mouse is used in the preclinical process of the discovery of drugs.

Number of employees: 65

JPY in Million	2022	Weight	2023	Weight	Delta
Pxb Mouse 100.0 %	1,325	100.0 %	2,124	100.0 %	+60.33%

JPY in Million	2022	Weight	2023	Weight	Delta
United States 69.0 %	601	45.3 %	1,466	69.0 %	+143.96%
Switzerland 18.5 %	174	13.1 %	393	18.5 %	+125.92%
Japan 9.3 %	358	27.0 %	198	9.3 %	-44.74%
Others 3.2 %	53	4.0 %	68	3.2 %	+27.19%

Managers	Title	Age	Since
Takashi Shimada PSD	President	65	02-03-03
Kenji Kuramoto CHM	Chairman	67	05-10-31
Chise Tateno-Mukaidani CTO	Chief Tech/Sci/R&D Officer	62	07-03-31
Yasuhiro Tamura ADM	Chief Administrative Officer	67	04-03-31
Yoshio Morikawa BRD	Director/Board Member	54	04-10-31
Masakazu Kakuni BRD	Director/Board Member	52	05-06-30
Masatsugu Ueda BRD	Director/Board Member	75	06-12-31

Members of the board	Title	Age	Since
Kenji Kuramoto CHM	Chairman	67	05-10-31
Takashi Shimada PSD	President	65	02-03-03
Yasuhiro Tamura ADM	Chief Administrative Officer	67	04-03-31
Chise Tateno-Mukaidani CTO	Chief Tech/Sci/R&D Officer	62	07-03-31
Yoshinori Fujii BRD	Director/Board Member	53	16-05-31
Masakazu Kakuni BRD	Director/Board Member	52	05-06-30
Yoshio Morikawa BRD	Director/Board Member	54	04-10-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	4,028,133	1,776,170 ( 44.09 %)	45 ( 0.001117 %)	44.09 %

Name	Equities	%	Valuation
Shunichi Morimoto 12.56 %	506,000	12.56 %	2 M ¥
Sanwa Shoji KK 6.808 %	274,218	6.808 %	829 457 ¥
Institute of Immunology Co., Ltd. 3.202 %	129,000	3.202 %	390 200 ¥
Eiken KK 2.185 %	88,000	2.185 %	266 183 ¥
SEKISUI CHEMICAL CO., LTD. 1.986 %	80,000	1.986 %	241 985 ¥
Shinya Yasuda 1.440 %	58,000	1.440 %	175 439 ¥
Chugai Technos Corp. 1.415 %	57,000	1.415 %	172 414 ¥
Takashi Shimada 0.8987 %	36,200	0.8987 %	109 498 ¥
Kenji Kuramoto 0.8739 %	35,200	0.8739 %	106 473 ¥
Yasuhiro Tamura 0.4766 %	19,200	0.4766 %	58 076 ¥

PhoenixBio Co., Ltd.

3-4-1 Kagamiyama

739-0046, Higashi-Hiroshima

http://www.phoenixbio.co.jp

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
PHOENIXBIO CO., LTD.	+6.44%	13.59M
MODERNA, INC.	+33.37%	50.85B
IQVIA HOLDINGS INC.	+1.55%	42.82B
LONZA GROUP AG	+49.96%	42.03B
CELLTRION, INC.	-4.22%	29.55B
ICON PUBLIC LIMITED COMPANY	+11.57%	26.11B
ALNYLAM PHARMACEUTICALS, INC.	-21.00%	19.13B
BIO-TECHNE CORPORATION	+7.36%	13.05B
MEDPACE HOLDINGS, INC.	+28.30%	12.16B
UNITED THERAPEUTICS CORPORATION	+23.80%	12.08B

Other Biotechnology & Medical Research